Despite strong evidence supporting combination therapy for metastatic hormone-sensitive prostate cancer, androgen-deprivation therapy monotherapy remains common. Do you think you know why? Take the quiz to...
This pop quiz asks about the treatment options currently recommended for individuals with unfavorable intermediate- or high-risk prostate cancer. Take the quiz to test your knowledge!
Disease risk stratification is essential to establishing an appropriate course of treatment in individuals with newly diagnosed prostate cancer. Are you familiar with the latest guidelines by the American...
